Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults
Clinical trial NCT00395174 · COMPLETED
Trial details
- NCT number
- NCT00395174
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-05-01
- Enrollment
- 870
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.